Texas Retina Associates Participating in Phase III Clinical Trial for Choroidal Melanoma
Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina is now participating in the Phase III AU-011 clinical trial (CoMpass) for treatment of small choroidal (ocular) melanoma. Together with Aura
read moreProtect Your Eyes as You Enjoy the April 8 Great American Eclipse
On April 8, 2024, North America will witness a rare total solar eclipse as the moon passes between the sun and the Earth, briefly blocking the sun’s rays for several minutes and darkening
read moreHonoring Our Physicians
Tomorrow, March 30, is National Doctor’s Day. At Texas Retina, we celebrate all 16 of our physicians as well as all of the physicians who care for our patients and communities. Thank
read moreTexas Retina Associates Led the Way at the 2024 VisionWalk to Benefit the Foundation Fighting Blindness
This past Saturday, Texas Retina Associates sponsored and participated in the 2024 Dallas-Fort Worth VisionWalk to benefit the Foundation Fighting Blindness and was recognized as the “Largest Team.” Our “Walk Stars” came
read moreDr. Abbey Recognized as a 2023 Top 10 Reviewer for Ophthalmic Surgery Lasers + Imaging Retina Medical Journal
The medical journal Ophthalmic Surgery Lasers + Imaging Retina (OSLI Retina) recently recognized Texas Retina Associates’ Ashkan M. Abbey, MD as a “2023 Top 10 Reviewer” in recognition of the quantity, quality
read moreDr. Abbey Featured as a Panelist in Retina Times Article on Secondary IOL Placement Surgery
In the Winter 2023 issue of Retina Times published by the American Society of Retina Specialists (ASRS), Texas Retina Associates’ Ashkan M. Abbey, MD, was featured in an article titled, “Managing the
read moreHappy New Year!
Happy New Year! Our offices will be closed on Monday, January 1, 2024. As another year comes to a close, we want to thank all of our patients, referring physicians, neighbors and
read more